• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Korea·Consumer Cyclical·090430.KS
Share

Amorepacific Corporation Stocks

₩ 120100Last Updated 28.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

₩ 4.75B

₩ 120100
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

22.11.2025 17:01

The return of metrosexuals: which companies will capitalize on men's love of cosmetics

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Amorepacific Corporation is a global enterprise engaged in the manufacturing and sale of beauty, household, and healthcare merchandise. The company's extensive offerings include a wide range of skincare products, such as cleansers, toners, hydrating fluids, moisturizers, eye treatments, concentrated serums, facial masks, and specialized care or travel-sized items. They also provide solutions for various skin concerns, including anti-aging, dryness, improving tone and texture, sun protection, and a diverse selection of makeup products. Founded in 1945, its main operational base is located in Seoul, South Korea.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 090430.KS is 160923 and suggests 36.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.07.2026 15:12

Shares of a small-cap company developing a treatment for vitiligo have skyrocketed. A competitor wants to buy it.

28.07.2026 13:47

An Nvidia employee was detained in Taiwan in connection with a case involving the smuggling of AI chips to China

28.07.2026 12:29

Samsung and SK Hynix Plummeted Ahead of Earnings Reports: News from China Fueled Investor Fears

28.07.2026 12:00

Is Cartier the New Birkin? Investors Are Looking for the Next Big Thing in the World of Luxury

28.07.2026 10:42

Top Stories This Morning: New U.S. Rules for AI, a Plunge in Chipmakers’ Stocks and the South Korean Stock Market

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026